Zymeworks Inc share price logo

Zymeworks Inc Share Price

NYSE: ZYME

Small Cap

$26.66

+0.14

(+0.55%)

as on

Zymeworks Inc Stock Performance

as on December 6, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $25.98
    $27
    downward going graph

    2.55%

    Downside

    1.28%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $9.03
    $28.49
    downward going graph

    66.13%

    Downside

    6.86%

    Upside

    downward going graph

Zymeworks Inc share price movements today

Previous Close
$26.52
Open
$26.68
Volume
589.8K
Day's Low - High
$25.98 - $27
52 Week Low - High
$9.03 - $28.49

Zymeworks Inc Historical Returns

1 Month Return
+ 46.43 %
3 Month Return
+ 75.61 %
1 Year Return
+ 86.13 %
3 Year Return
+ 246.85 %
5 Year Return
0 %

Zymeworks Inc Stock Fundamentals & Key Indicators

Check Zymeworks Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

-0.8794

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.51

Industry PE ratio

0.7131111111111111

PEG Ratio

0

EBITDA

-61.0M

Revenue (TTM)

134.5M

Profit Margin

-47.16%

Return On Equity TTM

-18.46%

Zymeworks Inc Stock Valuation

Track how Zymeworks Inc P/E has moved over time to understand its valuation trends.

Zymeworks Inc in the last 5 years

  • Overview

  • Trends

Lowest (-12.28x)

June 30, 2025

Today (-3.51x)

December 5, 2025

Industry (0.71x)

December 5, 2025

Highest (3.97x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.51x

Zymeworks Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zymeworks Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.0BNA-3.51-47.16%
BUY$43.7B410.81%-16.34-264.83%
BUY$62.5B258.57%1690.321.36%
BUY$118.7B100.27%30.4931.35%
BUY$76.7B46.78%17.3332.13%

Stock Returns calculator for Zymeworks Inc Stock including INR - Dollar returns

The Zymeworks Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Zymeworks Inc investment value today

Current value as on today

₹1,93,903

Returns

₹93,903

(+93.9%)

Returns from Zymeworks Inc Stock

₹87,746 (+87.75%)

Dollar Returns*

₹6,157 (+6.16%)

Analyst Recommendation on Zymeworks Inc Stock

Based on 14 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Zymeworks Inc. Average target price of $34.5

Zymeworks Inc Share Price Target

Get share price movements and forecasts by analysts on Zymeworks Inc.

What analysts predicted

22.72%UPSIDE

Target Price

$34.5

Current Price

$26.66

Analyzed by

14 Analysts

Target

$34.50

Zymeworks Inc target price $34.5, a slight upside of 22.72% compared to current price of $26.66. According to 14 analysts rating.

Zymeworks Inc Stock’s Investor Sentiment and Interest

Search interest for Zymeworks Inc Stock has increased by 1617% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1617% versus previous 30 day period

Zymeworks Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
7
16
16
10
19
16
31
27
48
27
Gross Profit
-32
16
16
10
19
16
31
27
48
27
Operating Income
-54
-33
-23
-37
-42
-34
-22
-25
0
-22
EBITDA
-51
-26
-20
-20
-23
-31
-18
-22
2
-15
Interest Expense
-
-
7
-
-
-
-
-
-
-
Depreciation
4
6
3
2
2
2
3
3
3
2
Income Before Tax
-49
-27
-19
-31
-37
-29
-17
-22
2
-18
Income Tax Expense
1
1
-4
0
0
0
5
0
0
1
Net Income
-51
-28
-14
-31
-37
-29
-23
-22
2
-19
Net Profit Margin
-730.53%
-173.80%
-85.56%
-315.58%
-195.84%
-186.56%
-75.75%
-83.50%
4.76%
-70.99%

Zymeworks Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
9
11
51
53
29
38
26
412
76
76
Gross Profit
-14
-24
10
53
-87
38
26
412
-66
76
Operating Income
-19
-37
-8
-33
-151
-187
-215
130
-138
-137
EBITDA
-18
-36
-6
-29
-148
-177
-206
142
-120
-108
Interest Expense
0
0
1
0
11
17
12
3
-
-
Depreciation
-
-
2
3
7
10
12
12
17
11
Income Before Tax
-19
-38
-9
-34
-144
-180
-212
135
-119
-116
Income Tax Expense
0
-5
0
2
0
0
0
10
0
6
Net Income
-19
-33
-10
-36
-145
-180
-211
124
-118
-122
Net Profit Margin
-198.45%
-307.10%
-20.10%
-68.95%
-492.27%
-463.54%
-794.01%
30.14%
-156.13%
-160.80%

Zymeworks Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-28
-14
-31
-37
-29
-23
-22
2
-19
Operating Cash Flow
-42
13
-37
-24
-5
-41
-3
12
-31
Investing Cash Flow
-7
-1
-7
-19
72
-6
12
8
0
Financing Cash Flow
1
50
2
1
-14
-8
1
1
-2
Change in Cash
-47
63
-42
-43
51
-56
10
22
-33

Zymeworks Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-33
-10
-36
-145
-180
-211
124
-118
-122
Operating Cash Flow
-35
0
24
-81
-151
-192
144
-118
-110
Investing Cash Flow
-25
-30
-109
-25
-43
144
-53
-207
38
Financing Cash Flow
64
49
91
193
308
8
108
81
-20
Change in Cash
4
19
6
86
113
-40
199
-243
-91

Global Institutional Holdings in Zymeworks Inc

Funds
Holdings
EcoR1 Capital, LLC
30.33%
Rubric Capital Management LP
6.22%
Bvf Inc
5.69%
Morgan Stanley - Brokerage Accounts
5.52%
Redmile Group, LLC
5.48%

Zymeworks Inc News & Key Events

  • img

    Today's Timeline - 17 November

    Mon, 07:11 PM

    -

    Zymeworks and Jazz Pharmaceuticals report Phase 3 trial results for Ziihera, with shares surging about 35%.

Insights on Zymeworks Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ZYME stock has moved up by 47.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 980.3% return, outperforming this stock by 704.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 171.9% return, outperforming this stock by 86.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 48.72M → 27.61M (in $), with an average decrease of 43.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 2.31M → -19.60M (in $), with an average decrease of 946.0% per quarter

About Zymeworks Inc

zymeworks is a privately held biotherapeutics company that is developing best-in-class azymetric™ bi specific antibodies and antibody drug conjugates for the treatment of oncology, autoimmunity and inflammatory diseases. the company’s novel azymetric™ and albucore™ platforms, and its proprietary zymecad™ structure-guided protein engineering technology, enable the development of highly potent bi-specific antibodies and multivalent protein therapeutics targeted across a range of indications. zymeworks is focused on accelerating its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations. more information on zymeworks can be found at www.zymeworks.com.
OrganisationZymeworks Inc
Headquarters108 Patriot Drive, Middletown, DE, United States, 19709
IndustryHealth Technology
CEOMr. Kenneth H. Galbraith C.A.
E-voting on sharesClick here to vote

Key Management of Zymeworks Inc

Name

Title

Mr. Kenneth H. Galbraith C.A.

Chairman of the Board, CEO & President

Dr. Paul A. Moore Ph.D.

Chief Scientific Officer

Dr. Lindsey Foulkes B.Sc., Ph.D.

Vice President of Corporate Development

Ms. Laura O'Connor

Vice President of Human Resources & DEI

Ms. Leone D. Patterson CPA, M.B.A.

Executive VP and Chief Business & Financial Officer

Mr. Scott Platshon B.Sc.

Acting Chief Investment Officer

Mr. Mark Hollywood

Executive VP and Head of Technical & Manufacturing Operations

Ms. Shrinal Inamdar

Director of Investor Relations

Mr. Daniel Dex J.D., Ph.D.

Senior VP, Corporate Secretary & General Counsel

Diana Papove

Senior Manager of Corporate Communications

FAQs

What is Zymeworks Inc share price today?

Zymeworks Inc share price today is $26.66 as on at the close of the market. Zymeworks Inc share today touched a day high of $27 and a low of $25.98.

What is the 52 week high and 52 week low for Zymeworks Inc share?

Zymeworks Inc share touched a 52 week high of $28.49 on and a 52 week low of $9.03 on . Zymeworks Inc stock price today i.e. is closed at $26.66,which is 6.42% down from its 52 week high and 195.24% up from its 52 week low.

What is Zymeworks Inc's market capitalisation today?

Zymeworks Inc market capitalisation is $0.00T as on .

How to invest in Zymeworks Inc Stock (ZYME) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zymeworks Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zymeworks Inc Shares that will get you 0.0563 shares as per Zymeworks Inc share price of $26.66 per share as on December 6, 2025 at 2:29 am IST.

What is the minimum amount required to buy Zymeworks Inc Stock (ZYME) from India?

Indian investors can start investing in Zymeworks Inc (ZYME) shares with as little as ₹89.927 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.27 in Zymeworks Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Zymeworks Inc share’s latest price of $26.66 as on December 6, 2025 at 2:29 am IST, you will get 0.3751 shares of Zymeworks Inc. Learn more about fractional shares .